FDA approves biologic drug for arthritis in cats

2022-01-14

The FDA approved Solensia, a monoclonal antibody drug from Zoetis, to treat arthritis pain in cats. The drug's active ingredient, frunevetmab, binds to a nerve growth factor protein and blocks pain signals from reaching the brain.

Full story:

Animal Health SmartBrief

Animal health news

Designed specifically for veterinarians, Animal Health SmartBrief is a FREE daily e-mail newsletter. It provides the latest news that matters to animal health professionals, including veterinary medicine updates, animal welfare and pet product news, best business practices, and regulatory updates.